Literature DB >> 22817741

The role of microRNA in the response to cisplatin treatment.

Ross M Drayton1.   

Abstract

Resistance to the cytotoxic effects of cisplatin can be mediated through changes in a wide variety of cellular processes and signalling pathways. The discovery of microRNAs as regulators of protein expression through the targeting of mRNA has led to a number of studies on the effect of cisplatin treatment on microRNA expression, and the ability of microRNAs to modulate cisplatin resistance.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22817741     DOI： 10.1042/BST20120055

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


  15 in total

1.  SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell.

Authors:  Chenzhe Feng; Fang Ma; Chunhong Hu; Jin-An Ma; Jingjing Wang; Yang Zhang; Fang Wu; Tao Hou; Shun Jiang; Yapeng Wang; Yeqian Feng
Journal:  Cell Cycle       Date:  2018-02-08       Impact factor: 4.534

2.  Pyrethroid-resistance is modulated by miR-92a by targeting CpCPR4 in Culex pipiens pallens.

Authors:  Kai Ma; Xixi Li; Hongxia Hu; Dan Zhou; Yan Sun; Lei Ma; Changliang Zhu; Bo Shen
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2016-09-11       Impact factor: 2.231

3.  MicroRNA-155 deficient mice experience heightened kidney toxicity when dosed with cisplatin.

Authors:  Kathryn L Pellegrini; Tao Han; Vanesa Bijol; Janani Saikumar; Florin L Craciun; William W Chen; James C Fuscoe; Vishal S Vaidya
Journal:  Toxicol Sci       Date:  2014-07-11       Impact factor: 4.849

4.  Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.

Authors:  Priya Samuel; Laura Ann Mulcahy; Fiona Furlong; Helen O McCarthy; Susan Ann Brooks; Muller Fabbri; Ryan Charles Pink; David Raul Francisco Carter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

5.  USP2a alters chemotherapeutic response by modulating redox.

Authors:  B Benassi; M Marani; M Loda; G Blandino
Journal:  Cell Death Dis       Date:  2013-09-26       Impact factor: 8.469

Review 6.  Molecular mechanisms of cisplatin resistance in cervical cancer.

Authors:  Haiyan Zhu; Hui Luo; Wenwen Zhang; Zhaojun Shen; Xiaoli Hu; Xueqiong Zhu
Journal:  Drug Des Devel Ther       Date:  2016-06-07       Impact factor: 4.162

7.  Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair.

Authors:  Man Xiao; Jing Cai; Liqiong Cai; Jinghui Jia; Lisha Xie; Ying Zhu; Bangxing Huang; Dongdong Jin; Zehua Wang
Journal:  J Ovarian Res       Date:  2017-04-04       Impact factor: 4.234

8.  Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1-miR-593-5p-MFF axis.

Authors:  Song Fan; Bodu Liu; Lijuan Sun; Xiao-bin Lv; Zhaoyu Lin; Weixiong Chen; Weiliang Chen; Qionglan Tang; Youyuan Wang; Yuxiong Su; Shaowen Jin; Daming Zhang; Jianglong Zhong; Yilin Li; Bin Wen; Zhang Zhang; Pu Yang; Bin Zhou; Qixiang Liang; Xing Yu; Yinghua Zhu; Pengnan Hu; Junjun Chu; Wei Huang; Yuhuan Feng; Hongzhuang Peng; Qihong Huang; Erwei Song; Jinsong Li
Journal:  Oncotarget       Date:  2015-06-20

9.  Redox-sensitive, PEG-shielded carboxymethyl PEI nanogels silencing MicroRNA-21, sensitizes resistant ovarian cancer cells to cisplatin.

Authors:  Sanaz Javanmardi; Ali Mohammad Tamaddon; Mahmoud Reza Aghamaali; Ladan Ghahramani; Samira Sadat Abolmaali
Journal:  Asian J Pharm Sci       Date:  2018-12-01       Impact factor: 6.598

10.  Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.

Authors:  Ross M Drayton; Ewa Dudziec; Stefan Peter; Simone Bertz; Arndt Hartmann; Helen E Bryant; James Wf Catto
Journal:  Clin Cancer Res       Date:  2014-02-10       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.